Lung Cancers Terminated Phase 2 Trials for Sorafenib (DB00398)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00754923Sorafenib in Treating Non-Smokers or Former Light Smokers With Relapsed or Refractory Stage IIIB or Stage IV Non-Small Cell Lung CancerTreatment
NCT00726986Sorafenib, Cisplatin, and Etoposide in Treating Patients With Extensive-Stage Small Cell Lung CancerTreatment